SCHEMBL16573271

SCHEMBL16573271

CC(=S)Nc1ccc(CCCC(N)=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.49
KDM1A O60341 1/20 0.47
AOC3 Q16853 1/20 0.46
F13A1 P00488 1/20 0.45
TGM2 P21980 1/20 0.45
NR1H4 Q96RI1 1/20 0.45
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
TRPV1 Q8NER1 1/20 0.44
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16573285 0.92 ALDH1A1 (0.48) POLBAOC3NR1H4HDAC3HDAC4
SCHEMBL16573272 0.84 EPHX2 (0.55) POLBSMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL7688792 0.81 ALDH1A1 (0.47) POLBAOC3HDAC3HDAC4HDAC1
SCHEMBL10360661 0.80 SPHK1 (0.49) POLBKDM1AF13A1TGM2NR1H4
SCHEMBL28693818 0.80 KDM1A (0.44) POLBKDM1AF13A1TGM2NR1H4
Hydrochloric Acid SCHEMBL10360586 0.79 SPHK1 (0.50) POLBKDM1AAOC3F13A1TGM2
SCHEMBL30779193 0.78 AOC3 (0.60) POLBAOC3NR1H4HDAC3HDAC4
SCHEMBL16573306 0.77 HDAC1 (0.51) POLBHDAC3HDAC4HDAC1HDAC7
SCHEMBL547069 0.76 CA12 (0.50) KDM1ANR1H4HDAC3HDAC4HDAC1
SCHEMBL3658863 0.76 CYP17A1 (0.53) KDM1ANR1H4HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2444085-B1 Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer UNIV CALIFORNIA (US) 2015-03-18 EP disclosed